Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

NCT00607763 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Candidiasis
Esophageal Candidiasis
Oropharyngeal Candidiasis
Candidemia

Interventions

DRUG: Micafungin (Mycamine)

Sponsor

Astellas Pharma Inc